MedTrace Logo

Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit

NCT02043223 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2016-09-21

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of post-partum maternal vitamin A supplementation on breast milk bioactive compounds and immune status, growth and morbidity of children in the first four months of life.

Conditions

  • Vitamin A Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin A (<3-day postpartum)

Single dose 200,000 IU vitamin A supplementation at \<3-day and placebo supplementation at 6-wk postpartum.

DIETARY_SUPPLEMENT

Vitamin A (6 wk postpartum)

Placebo supplementation at \<3-day and single dose 200,000 IU vitamin A supplementation at 6-wk postpartum.

DIETARY_SUPPLEMENT

Vitamin A (<3-day and 6 wk postpartum)

200,000 IU vitamin A supplementation, both at \<3-day and 6-wk postpartum

DIETARY_SUPPLEMENT

Placebo

Placebo supplementation, both at \<3-day and 6-wk postpartum.

Sponsors & Collaborators

  • Peter Bergman, MD, PhD

    collaborator UNKNOWN

  • Karolinska University Hospital

    collaborator OTHER

  • International Centre for Diarrhoeal Disease Research, Bangladesh

    lead OTHER

Principal Investigators

  • Shaikh M Ahmad, Ph.D · International Centre for Diarrhoeal Disease Research, Bangladesh

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
32 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-07-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02043223 on ClinicalTrials.gov